- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Kirsten rat sarcoma (KRAS) proto-oncogene, GTPase
Total 32910 results
-
AstraZenecaCompletedNon Small Cell Lung CancerUnited States, Belgium, France, Italy, Spain, Canada, Brazil, Hungary, Peru, Czechia, Bulgaria, Mexico
-
British Columbia Cancer AgencyCompleted
-
Roswell Park Cancer InstituteBristol-Myers SquibbTerminatedColorectal CancerUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenTerminatedKRAS Wild Type | Resectable Type II Gastric AdenocarcinomaAustria
-
Mirati Therapeutics Inc.Boehringer IngelheimCompletedMetastatic Cancer | Advanced Cancer | Malignant Neoplasm of Colon | Malignant Neoplasm of Lung | Malignant Neoplastic DiseaseUnited States
-
University Hospital Center of MartiniqueCompletedColorectal CarcinomaFrance
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
Shanghai Chest HospitalNovartis; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; BeiGeneNot yet recruitingKRAS Mutation-Related Tumors | Advanced Lung Cancer | Refractory TumorChina
-
Infinity Pharmaceuticals, Inc.CompletedNon-small Cell Lung CancerUnited States
-
AmgenActive, not recruitingColorectal Cancer (CRC)France, Spain, Korea, Republic of, United States, United Kingdom, Taiwan, Italy, Greece, Australia, Japan, Germany, Mexico
-
Betta Pharmaceuticals Co., Ltd.RecruitingMetastatic Cancer | Malignant NeoplasmsChina
-
Tianjin Medical University Cancer Institute and...RecruitingSintilimab, Cetuximab, Regorafenib,Combine,mCRCChina
-
GERCOR - Multidisciplinary Oncology Cooperative...AstraZenecaActive, not recruitingMetastatic Pancreatic AdenocarcinomaFrance
-
Vejle HospitalCompletedCholangiocarcinomaDenmark
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid TumoursUnited States, United Kingdom
-
Mirati Therapeutics Inc.Aadi Bioscience, Inc.Active, not recruitingNSCLC | Metastatic Cancer | Advanced Cancer | Solid Tumor, Adult | Malignant Neoplastic DiseaseUnited States
-
GCS IHFB Cognacq-JayRecruiting
-
Regione LombardiaMario Negri Institute for Pharmacological Research; Istituto Clinico Humanitas and other collaboratorsCompletedColorectal CancerItaly
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
Quanta TherapeuticsRecruiting
-
Quanta TherapeuticsRecruiting
-
University of UtahAmgen; Eisai Inc.Completed
-
Dana-Farber Cancer InstituteCompletedSolid Tumors | KRAS Mutant Non-Small Cell Lung CancerUnited States
-
Joint Authority for Päijät-Häme Social and Health...Helsinki University Central HospitalCompletedActinic KeratosesFinland
-
Verastem, Inc.RecruitingMetastatic Cancer | Pancreas Cancer | Neoplasms Pancreatic | KRAS Activating Mutation | Malignant Neoplasm of PancreasUnited States
-
AstraZenecaLaboratorio ProgeneticaCompletedNon Small Cell Lung CancerBrazil
-
University Hospital, EssenCompletedLung Adenocarcinoma Metastatic
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Stand Up To CancerRecruitingMutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic CancerPancreatic Cancer | High Risk CancerUnited States
-
Elicio TherapeuticsActive, not recruitingColorectal Cancer | Ovarian Cancer | Cholangiocarcinoma | Bile Duct Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma | Minimal Residual Disease | Gallbladder Carcinoma | KRAS G12D | KRAS G12R | NRAS G12D | NRAS G12RUnited States
-
Istituto Clinico HumanitasCompletedColorectal NeoplasmsItaly
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Traws Pharma, Inc.CompletedAdenocarcinoma | Non-small Cell Lung Cancer | Stage IVUnited States
-
PfizerTerminatedPancreatic CancerBelgium, United States, Singapore
-
AmgenCompletedMetastatic Colorectal Cancer
-
PD Dr. med. Volker HeinemannAmgenUnknownColorectal Cancer | KRAS Wildtype | After Resection of Liver MetastasesGermany
-
Navire Pharma Inc., a BridgeBio companyBristol-Myers SquibbRecruitingSolid Tumor | Non Small Cell Lung CancerUnited States
-
Jacobio Pharmaceuticals Co., Ltd.Active, not recruiting
-
Targovax ASACompletedPancreatic Cancer, ResectedNorway, Spain, United Kingdom
-
Boston UniversityCompleted
-
UNICANCERCompletedKRAS Gene Mutation | Infiltrating Urothelial CarcinomaFrance
-
The Netherlands Cancer InstituteLustgarten FoundationRecruitingColorectal Cancer | Pancreatic Cancer | Non-small Cell Lung Cancer | KRAS Mutation-Related TumorsNetherlands
-
Mirati Therapeutics Inc.RecruitingMetastatic Lung Cancer | Advanced NSCLCUnited States, Spain, France, Hungary, Italy, Greece, Poland, Brazil, Chile, Georgia, Malaysia, Serbia, Switzerland, Thailand
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Boston UniversityCompleted
-
The Netherlands Cancer InstituteGlaxoSmithKlineUnknown
-
AmgenCompletedMetastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal Cancer
-
Mirati Therapeutics Inc.Active, not recruitingMetastatic Colorectal Cancer | Advanced Colorectal CancerUnited States, Spain, Belgium, Canada, France, Italy, United Kingdom, Korea, Republic of, Austria, Denmark, Taiwan, Germany, Malaysia, Czechia, Colombia, Singapore, Australia, Thailand, Netherlands, Romania, Greece, Brazil, Argentina, Polan... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | KRAS Gene Mutation | Metastatic Malignant Solid Neoplasm | EGFR Gene Mutation | ERBB2 Gene Amplification | ERBB2 Gene Mutation | EGFR Gene Amplification | ERBB3 Gene Mutation | ERBB4 Gene MutationUnited States